Clinical Trial Update: Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial update for ABBV-932 in adults with Bipolar I or Bipolar II disorder, assessing adverse events and changes in disease activity; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• ABBV-932

Snippet

Sponsor: AbbVie | Conditions: Bipolar I Disorder, Bipolar II Disorder | Phase 2 | Status: COMPLETED